HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter H Jones Selected Research

Therapeutics

9/2021Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH).
5/2019The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.
10/2017Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics.
5/2016Provider understanding of the 2013 ACC/AHA cholesterol guideline.
11/2015National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
3/2015National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
10/2014Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS Studies.
9/2014National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.
11/2012Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
3/2012LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter H Jones Research Topics

Disease

25Dyslipidemias (Dyslipidemia)
10/2017 - 08/2003
23Coronary Disease (Coronary Heart Disease)
01/2019 - 01/2003
20Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 02/2004
10Obesity
03/2016 - 06/2004
9Atherosclerosis
01/2019 - 08/2003
8Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 03/2004
8Inflammation (Inflammations)
01/2016 - 06/2004
8Hypercholesterolemia
10/2014 - 01/2003
6Myocardial Infarction
05/2019 - 02/2007
5Hypertriglyceridemia
11/2013 - 02/2004
5Weight Loss (Weight Reduction)
11/2013 - 06/2004
4Stroke (Strokes)
05/2019 - 01/2007
4Diabetes Mellitus
01/2019 - 01/2008
4Type 2 Diabetes Mellitus (MODY)
01/2010 - 01/2007
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
09/2021 - 01/2016
3Hyperlipidemias (Hyperlipidemia)
03/2006 - 11/2005
2Respiratory Tract Infections (Respiratory Tract Infection)
12/2016 - 12/2008
2Hypertension (High Blood Pressure)
03/2015 - 01/2008
2Insulin Resistance
02/2010 - 06/2004
2Myotoxicity
01/2010 - 01/2005
2Rhabdomyolysis
01/2010 - 01/2005
2Muscular Diseases (Myopathy)
12/2008 - 02/2008
2Coronary Artery Disease (Coronary Atherosclerosis)
03/2007 - 02/2007
1Prediabetic State (Prediabetes)
01/2019
1Hyperlipoproteinemia Type III (Broad Beta Disease)
09/2018
1Injection Site Reaction
12/2016
1Diabetes Complications
12/2016
1Pruritus (Itching)
12/2016
1Ischemic Stroke
12/2016
1Unstable Angina
12/2016
1Immune System Diseases (Immune Disorders)
01/2016
1Virus Diseases (Viral Diseases)
01/2016
1Rheumatoid Arthritis
11/2015
1Carotid Artery Diseases
10/2014
1Carotid Stenosis (Carotid Artery Stenosis)
10/2014
1Tangier Disease
01/2013
1Weight Gain
02/2010
1Glucose Intolerance
02/2010

Drug/Important Bio-Agent (IBA)

34LipidsIBA
05/2016 - 08/2003
30Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2021 - 01/2003
22LDL CholesterolIBA
09/2021 - 01/2003
16oxidized low density lipoproteinIBA
09/2021 - 01/2003
16CholesterolIBA
05/2019 - 01/2003
12HDL CholesterolIBA
11/2015 - 02/2004
10Rosuvastatin Calcium (Crestor)FDA Link
10/2014 - 01/2003
10fenofibric acidFDA Link
11/2012 - 12/2008
9Triglycerides (Triacylglycerol)IBA
01/2016 - 07/2003
9Atorvastatin (Lipitor)FDA Link
10/2014 - 01/2003
6Lipoproteins (Lipoprotein)IBA
01/2016 - 11/2012
6Simvastatin (Zocor)FDA LinkGeneric
02/2011 - 01/2003
5Proteins (Proteins, Gene)FDA Link
09/2018 - 03/2012
5Ezetimibe (Zetia)FDA Link
12/2016 - 08/2003
5Fibric Acids (Fibrates)IBA
03/2012 - 01/2005
4Hormones (Hormone)IBA
03/2016 - 06/2004
4Biomarkers (Surrogate Marker)IBA
01/2016 - 07/2005
4Bile Acids and Salts (Bile Acids)IBA
01/2016 - 08/2003
4ApolipoproteinsIBA
03/2015 - 09/2004
4Fenofibrate (CiL)FDA LinkGeneric
12/2008 - 07/2004
4Pravastatin (Pravachol)FDA LinkGeneric
02/2005 - 01/2003
3Pharmaceutical PreparationsIBA
09/2018 - 11/2005
3LDL Lipoproteins (beta Lipoproteins)IBA
11/2017 - 01/2003
3MineralsIBA
03/2016 - 01/2016
3VitaminsIBA
03/2016 - 01/2016
3FatsIBA
03/2016 - 01/2016
3CarbohydratesIBA
03/2016 - 01/2016
3Trace Elements (Biometals)IBA
03/2016 - 01/2016
31-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
10/2014 - 06/2008
3Apolipoprotein A-I (Apolipoprotein A1)IBA
11/2013 - 09/2004
3Glucose (Dextrose)FDA LinkGeneric
02/2011 - 06/2004
3Niacin (Nicotinic Acid)FDA LinkGeneric
03/2006 - 08/2003
2Lipoprotein(a)IBA
05/2019 - 01/2019
2alirocumabIBA
12/2016 - 10/2014
2Immunologic Factors (Immunomodulators)IBA
01/2016 - 01/2016
2CC ChemokinesIBA
02/2010 - 01/2006
2Messenger RNA (mRNA)IBA
02/2010 - 01/2006
2Gemfibrozil (Lopid)FDA LinkGeneric
12/2008 - 01/2005
2Adenosine Triphosphate (ATP)IBA
03/2006 - 01/2003
2LeptinIBA
07/2005 - 06/2004
2Insulin (Novolin)FDA Link
07/2005 - 06/2004
18- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
09/2021
1Blood Glucose (Blood Sugar)IBA
01/2019
1LDL Receptors (LDL Receptor)IBA
09/2018
1Proprotein Convertase 9IBA
10/2017
1CalciumIBA
10/2014
1HDL LipoproteinsIBA
11/2013
1Cholesterol Esters (Cholesteryl Esters)IBA
01/2013
1ATP Binding Cassette Transporter 1IBA
01/2013
1Apolipoprotein C-IIIIBA
03/2012
1LigandsIBA
02/2010
1Interferon-gamma (Interferon, gamma)IBA
02/2010
1C-Reactive ProteinIBA
01/2010
1Drug CombinationsIBA
10/2009
12- (4- (4- chlorobenzoyl)phenoxy)- 2- methylpropanoic acidIBA
05/2009

Therapy/Procedure

34Therapeutics
09/2021 - 01/2003
7Drug Therapy (Chemotherapy)
01/2016 - 07/2004
4Bariatric Surgery
03/2016 - 01/2006
2Blood Component Removal (Apheresis)
01/2016 - 11/2014
1Plasmapheresis
09/2018
1Injections
09/2018
1Fat-Restricted Diet (Diet, Fat Restricted)
02/2010